Oral Peanut Immunotherapy for Peanut Allergic Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Peanut Hypersensitivity
Interventions
DRUG

Peanut protein

Subjects will receive increasing amounts of peanut protein over the modified rush phase and the build-up phase of the protocol. Once the subject reaches the maintenance phase of the study, they will remain on that dose until they reach the oral food challenges at the end of the study.

Trial Locations (1)

27599

UNC Chapel Hill, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT01891136 - Oral Peanut Immunotherapy for Peanut Allergic Patients | Biotech Hunter | Biotech Hunter